Cargando…
Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells
Due to tumor heterogeneity, most believe that effective treatments should be tailored to the features of an individual tumor or tumor subclass. It is still unclear, however, what information should be considered for optimal disease stratification, and most prior work focuses on tumor genomics. Here,...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078165/ https://www.ncbi.nlm.nih.gov/pubmed/30082272 http://dx.doi.org/10.15252/msb.20188322 |